MDXG MiMedx Group Inc Total Asset Value of Company

MDXG (MiMedx Group) - company brandmark

Geopolitical tensions create risks for raw material logistics and patent protection for MiMedx Group, Inc. (MDXG). The historical price action of total assets on GURU.Markets is 286.24. A steady inflow of funds ensures the demand for placental products in clinics. Meanwhile, the development of regenerative drugs is hindered by the complexity of automating work with live cells, which requires significant involvement of qualified personnel.

MDXG (MiMedx Group, Inc.) Company Total Assets history from 07/04/2022 to 10/29/2026

Analytical breakdowns and data insights for company MiMedx Group (MDXG)

- market price and analyst price targets:
Price Rate Chart mimedx.com|MDXG - Price Target Chart
- market capitalization data:
Market Valuation MiMedx Corp|MDXG - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share MiMedx|MDXG - Book Capitalization|Market Capitalization to Book Value Ratio mimedx.com|MDXG - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio MiMedx Group, Inc.|MDXG - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio MiMedx Corp|MDXG - Company Aggregate Debts|Debts to Book Capitalization MiMedx Corp|MDXG - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings MiMedx|Quick Liquidity Indicator mimedx.com
- net income and valuation multiples indicators:
MDXG - Net Profit
Fundamental valuation:MiMedx Group, Inc.
Manufactured products of MiMedx Group, Inc.

Total assets represent the aggregate value of the company's resources, calculated inversely via ROA to assess capital efficiency relative to WACC. By analyzing the enterprise's gross assets, an investor determines the ability of MiMedx Group, Inc. (MDXG) to scale its unique base of biologics and cellular technologies, converting asset growth into a standard of care for chronic tissue damage.

Key competitors

Company Balance Sheet Assets ascendispharma.com ASND|Aggregate Company Assets Madrigal Pharmaceuticals, Inc.|Corcept Therapeutics Inc. - Total Asset Value of Company|Company Total Assets RYTM|AKRO (Akero Corp) - Aggregate Asset Value|Company Total Assets MTSR (Metsera Inc)|Company Total Assets moonlaketx.com MLTX|CRNX - Aggregate Company Assets|Aggregate Asset Value NAMS (NewAmsterdam Pharma Company)|Soleno (SLNO) - Aggregate Company Assets|Cumulative Company Assets Amicus Corp|ETNB (89bio, Inc.) - Company Total Assets|Company Total Assets agios.com|Cumulative Company Assets GPCR (Structure Therapeutics Inc.)|RZLT (Rezolute Inc) - Aggregate Asset Value|Aggregate Company Assets Lexicon Pharma LXRX|MBX - Cumulative Company Assets|Altimmune, Inc. - Company Total Assets|Company Assets aardvarktherapeutics.com|SGMT (Sagimet Biosciences Inc.) - Cumulative Company Assets|BIOA: Aggregate Business Assets|BMEA (Biomea) - Company Total Assets|Company Total Assets Quince|Company Total Assets GUTS|Aggregate Company Assets VTVT (vtvtherapeutics.com)|Aggregate Company Assets Agape ATP ATPC|Pluristem Therapeutics (PLUR) - Company Assets|SYBX - Aggregate Company Assets|LPCN: Aggregate Company Assets|MTNB: Company Total Assets|SPRB - Company Total Asset Base|Aggregate Company Assets Galecto|Carmell Corp. (CTCX) - Company Total Asset Base|Aggregate Company Assets Lumos Pharma Corp (LUMO)|Cumulative Company Assets Organovo Corp ONVO|Aggregate Company Assets Radius Recycling, Inc. RDUS